To include your compound in the COVID-19 Resource Center, submit it here.

DAC:Opioid: Phase II

ConjuChem Inc. (TSE:CJC), Montreal, Quebec
Business: Neurological
Product: DAC:Opioid (CJC-1008)
Therapeutic category:

Read the full 120 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE